spirobromin has been researched along with cytarabine in 1 studies
*Cytarabine: A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) [MeSH]
*Cytarabine: A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grasmane, DV; Iavorskiĭ, LI | 1 |
1 other study(ies) available for spirobromin and cytarabine
Article | Year |
---|---|
[Acute leukemia with blasts in the shape of a hand mirror].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Histocytochemistry; Humans; Leukemia, Myeloid, Acute; Lymphocytes; Male; Middle Aged; Spiro Compounds; Vincristine | 1987 |